Abstract | OBJECTIVES: STUDY DESIGN: Systematic review. METHODS: We searched PubMed, Embase, Cochrane Library and clinicaltrials.gov for articles through January 2016. We included studies of Cu-IUD or LNG-IUD users comparing IUD-specific (perforation, expulsion) and other contraceptive-related ( infection, removal/cessation due to bleeding/ pain and other adverse events) outcomes for breastfeeding vs. non-breastfeeding women. We also included studies of breastfeeding women comparing contraceptive-related outcome for IUD-users vs. other contraceptive-method users. Finally, we included studies comparing breastfeeding outcomes among Cu-IUD users to users of other nonhormonal contraceptives or no contraception. RESULTS: Of 548 articles identified, 23 (16 studies) met the inclusion criteria. Two studies suggested that the risk of IUD perforation was 6-10 times higher among breastfeeding vs. non-breastfeeding women. Seven studies suggested that risks for other adverse events were similar or lower among breastfeeding vs. non-breastfeeding women. Three studies among breastfeeding women found no increased risk of adverse events in IUD users vs. nonusers. Breastfeeding performance and infant growth were similar for Cu-IUD users and users of other nonhormonal methods or no contraception. CONCLUSION: Overall, risks for adverse events among IUD users, including expulsion, pain and removals, were similar or lower for breastfeeding women vs. non-breastfeeding women. Uterine perforation with IUDs, while rare, appeared more frequent among breastfeeding women. No evidence indicated that Cu-IUD use in breastfeeding women influences breastfeeding performance or infant growth.
|
Authors | Erin N Berry-Bibee, Naomi K Tepper, Tara C Jatlaoui, Maura K Whiteman, Denise J Jamieson, Kathryn M Curtis |
Journal | Contraception
(Contraception)
Vol. 94
Issue 6
Pg. 725-738
(12 2016)
ISSN: 1879-0518 [Electronic] United States |
PMID | 27421765
(Publication Type: Journal Article, Review, Systematic Review)
|
Copyright | Copyright © 2016 Elsevier Inc. All rights reserved. |
Chemical References |
- Contraceptive Agents, Female
- Levonorgestrel
|
Topics |
- Breast Feeding
- Contraception
(methods)
- Contraceptive Agents, Female
(administration & dosage)
- Equipment Safety
- Female
- Humans
- Intrauterine Devices, Copper
(adverse effects)
- Levonorgestrel
(administration & dosage)
- Postpartum Period
- Randomized Controlled Trials as Topic
- Risk Assessment
- Uterine Perforation
(etiology)
|